MICU intern's survival guide vasopressors: Difference between revisions
Jump to navigation
Jump to search
| Line 6: | Line 6: | ||
* Indications: | * Indications: | ||
** [[Septic shock]] | ** [[Septic shock]] | ||
** [[Cardiogenic shock]] - Recent studies have shown that [[norepinephrine]] may be better than [[dobutamine]] in cardiogenic shock due to decreased | ** [[Cardiogenic shock]] - Recent studies have shown that [[norepinephrine]] may be better than [[dobutamine]] in [[cardiogenic shock]] due to a decreased risk of [[tachyarrhythmia]]s. | ||
** In cases where the type of shock is unclear norepinephrine can be tried as first line agent. | ** In cases where the type of shock is unclear, [[norepinephrine]] can be tried as a first line agent. | ||
** Doses - 1- | ** Doses - 1-30 mcg/min. | ||
===Dobutamine=== | ===Dobutamine=== | ||
Revision as of 17:06, 27 December 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Norepinephrine
- Mechanism of action - Acts on both alpha1 (vasoconstriction of blood vessels) and beta1 receptors (increases cardiac output).
- Indications:
- Septic shock
- Cardiogenic shock - Recent studies have shown that norepinephrine may be better than dobutamine in cardiogenic shock due to a decreased risk of tachyarrhythmias.
- In cases where the type of shock is unclear, norepinephrine can be tried as a first line agent.
- Doses - 1-30 mcg/min.